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1. Introduction
Reelin is an extracellular matrix glycoprotein of ~400 kD, expressed in mammals during
neurodevelopment by the Cajal-Retzius (CR) neurons, which are located in the marginal
zone of the cortex and hippocampus [1], and by the cerebellar granule cells [2]. In adult
stages,  CR neurons degenerate in both structures [3],  limiting Reelin production and se‐
cretion to  GABAergic  interneurons [4].  Meanwhile,  the  expression in  the cerebellum re‐
mains  being  exclusive  of  granule  cells  [5].  During  development,  Reelin  synthesis  also
occurs in structures like the hypothalamus, the olfactory bulb, the basal ganglia and the
amygdale.  In  these  last  two  brain  regions,  Reelin  expression  continues  into  adulthood
but at low concentrations [1].
Reelin gene encompasses 450 kb of genomic DNA located on human chromosome 7q22 and
in murine chromosome 5. Both genes contain 65 exons that encode a protein sharing a 94,2
(%) of identity [6-7]. The transcription initiation region and the exon 1 of the reelin gene is
enriched in CG nucleotides, forming a large CpG island [8], which is associated with a meth‐
ylation-dependent negative regulation of reelin transcription [9]. In fact, DNA methyltrans‐
ferases and histone deacetylases inhibitors increase Reelin protein expression, most likely
due to decreased reelin promoter methylation [10-11].
In addition to the epigenetic regulation, reelin gene show multiple cis elements, which con‐
tain binding sites for transcription factors involved in neurodevelopment such as Sp1, Tbr-1
and Pax6, and elements involved in cytoplasm-to-nucleus signal transduction as CREB and
NF-κB [7,12]. Tbr-1 deficient mice show a clear disruption of cortical organization, accompa‐
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nied by decreased Reelin levels [13]. On the other hand, retinoic acid, a known inducer of
neuronal growth and differentiation, increase Pax6 and Sp1 levels leading to the activation
of the reelin promoter and a subsequent increased Reelin protein synthesis [14].
The full length Reelin protein contains 3461 amino acids, organized from N- to C-terminal
by the following domains and motifs: 1.- A signal peptide, 2.- F-spondin-like motif, 3.- 8 re‐
peat domains, composed of a region A and region B spaced by EGF motif, and 4.- A region
enriched in basic amino acids [2].
Reelin may undergo proteolytic cleavage at the beginning of the 3rd and 7th A-EGF-B repeat
generating many fragments including the N-terminal, the intermediate segment and the C-
terminal fragment. Cleavage may be precluded by zinc chelators, known inhibitors of metal‐
loproteinases [15]. Recently a putative protease had been identified as p50 and p70 isoforms
of a disintegrin and metalloproteinase with thrombospodin motif 4 (ADAMTS-4). The p50
isoform cleaves at N-terminal only, and p70 cleaves the N- and C-terminal sites [16]. The im‐
portance of the proteolytic processing remains unclear, however; several reports showed
that the internalization of Reelin at target cells is independent of its cleavage. In turn, only
the central region seems to be sufficient for Reelin functions. Reelin cleavage would be re‐
quired to enable Reelin secretion, allowing the release of a central, active fragment from the
extracellular matrix-attached full length protein [17-18]. In contrast to this notion, there are
many studies showing that the N-terminal region is important for Reelin secretion (due to
the presence of a signal peptide on this region) [19], and to promote the formation of homo‐
polymers, which are essential for proper signal transduction [20]. There is still little evidence
about the function of the C-terminal region. The reeler Orleans mutation characterized by a
deletion of 220 nucleotides at the C-terminal, prevents the secretion of Reelin, suggesting a
possible role for this region in normal Reelin functions [21].
2. Reelin in neurodevelopment
As outlined in the previous section, Reelin is a glycoprotein, which is expressed in CR neu‐
rons starting at embryonic day 11 (E11), mainly in the cortex, hippocampus and cerebellum.
It expression remains high until day E18, when CR neurons begin to degenerate [1,3]. The
importance of Reelin to neurodevelopment had been elucidated through numerous studies
using a mice model exhibiting a spontaneous mutation (partial deletion) in the reelin gene,
called the reeler mice [22]. These mice had pronounced defects in the correct neuronal posi‐
tioning in the laminar structures of the brain. At day E11, postmitotic neurons located in the
ventricular zone, migrate toward the pial surface to form the preplate. On E13, a new cohort
of migrating neurons originated at the proliferative region separate the pre-plate. Pre-plate
splitting originates two regions, the marginal zone and the sub-plate, which are positioned
adjacent to the pial surface and near the ventricular zone, respectively. The marginal zone is
rich in CR neurons, which are the primary source of Reelin during neurodevelopment. Sev‐
eral waves of postmitotic migrating neurons are positioned between the marginal zone and
the sub plate, leading to the formation of the cortical plate. During the E14-E18 time lapse,
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four successive waves of postmitotic neurons migrate from the ventricular zone, through the
sub-plate and neurons already positioned, to reach the marginal zone where the Reelin se‐
creted by the CR neurons acts as a “stop signal” inducing the termination of the neuronal
migration. This process is termed as "radial migration", and occurs through an inside-out
mechanism, where early migrating neurons are placed at the inner aspects of the cortex [23].
Mechanistically, cortical neurons migrate using two different mechanisms, a glial-depend‐
ent process termed locomotion; and a glial-independent one termed nuclear translocation.
During migration across the cortical plate, the neurons adopt morphology characterized by
the presence of a cytoplasmic extension oriented toward the most outer aspect of the cortex,
the leading process. A secondary cytoplasmic extension emerge orthogonally from the lead‐
ing process and is termed the trailing process. While the leading process will be further de‐
veloped as the dendritic arbor, the trailing process will become the axon [24].
The reeler mutant shows a clear disruption of the cortical layers, characterized by the ab‐
sence of pre-plate splitting, generating a structure called the superplate [25]. Additionally,
migrating neurons fail to establish an inside-out pattern of cortical layers [26]. Thus, in the
reeler mutant, neurons that migrate earlier during development are placed in the outer as‐
pect of the cortex, leading to an outside-in pattern of cortical layers [23,27-29].
Abnormal neuronal migration is not exclusively for the reeler mice cortex. Purkinje neurons
in the cerebellum are also aberrantly organized. After birth, the Purkinje cell layer is absent,
and a reduction of granule cells number is appreciated, these alterations result in a dramatic
reduction of foliation pattern and diminished cerebellar size [30]. At the hippocampal re‐
gion, the reeler mutant is characterized by the presence of non-compacted dentate gyrus and
disorganized pyramidal layer [31].
Summarizing, Reeler brain shows smaller size and larger ventricles, the distribution of the
dorsal, medial and ventral hippocampus is altered, the cortex display an inverted array of
neurons in their layers and the cerebellum shows no foliation and alterations in the organi‐
zation of its layers [32].
At the molecular level, the Reelin signaling pathway control several processes required for
proper neuronal migration. For example, Reelin stabilize the leading process by inducing
cofilin phosphorylation at Ser3, which regulates actin dynamics [33]. Furthermore, Reelin
can also induce MAP1B phosphorylation through GSK-3β activation. MAP1B function is in‐
volved in formation of brain laminated areas, therefore, Reelin can modulate neuronal guid‐
ance through post-translational modifications of MAP1B [34]. These two examples show
how Reelin can act coordinately to locally regulate the assembly of actin microfilaments and
microtubules (Figure 1A).
In addition to its role in neurodevelopment, Reelin controls the formation of neural circuits,
promoting the growth and branching of dendrites in hippocampal neurons [35]. Moreover,
Reelin can enhance the formation of dendritic spines, supporting a role at the post-synaptic
compartment [36].
Most of these cellular functions are dependent on a signaling pathway, triggered by the
binding of Reelin to its two main receptors, the very-low density lipoprotein receptor
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(VLDLR) and the ApolipoproteinE receptor 2 (ApoER2) [37]. The binding of Reelin to its re‐
ceptor induce the phosphorylation of the adapter protein mDab1 on tyrosine residues [38].
mDab1 phosphorylation lead eventually to the modulation of cytoskeleton effectors mole‐
cules such as MAP1B and cofilin [23].
Figure 1. Reelin signaling pathway in normal brain and its impairment in AD brains. The panel A show the intracellular
events triggered by the binding of Reelin to its canonical membrane receptors, ApoER2 and VLDLR. mDab1 protein is spe‐
cifically phosphorylated at tyrosine residues, which concomitantly with the activation of PI3K, regulate actin and microtu‐
bule dynamic behavior. LIMK-mediated phosphorylation of cofilin and the Akt inhibitory phosphorylation of GSK-3β are
essential to this regulation. On the other hand, in AD brains, diminished Reelin expression and its aggregation in amyloid-
like deposits, induce impairment in its signaling pathway (represented by gray lines). Decreased Reelin signaling triggers
the dephosphorylation of cofilin, promoting the formation of actin-rods. On the other hand, the activation of GSK-3β and
CDK-5, lead to hyperphosphorylation of tau protein inducing its aggregation into PHFs (panel B).
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3. Reelin in the adult brain
Although Reelin function is mainly related to neurodevelopment, several recently studies
assign roles in the adult brain, such as the development of dendrites and dendritic spines
[36], modulation of synaptogenesis [39], modulation of synaptic plasticity [40-43] and neuro‐
transmitter release [44]. The mechanism by which Reelin can modulate the synaptic trans‐
mission is not fully elucidated. Currently it is strongly suggested that Reelin acting through
its canonical signaling pathway facilitates the phosphorylation of NR2A and NR2B subunits
of the NMDA receptor, favoring the calcium influx into the postsynaptic neuron.
This intracellular calcium increase causes the insertion of the GluR1 subunit of AMPA re‐
ceptors, allowing the phosphorylation and nuclear translocation of CREB [45]. CREB phos‐
phorylation is required to elicit the formation of dendritic spines. In addition, Reelin reduces
the number of silent synapses, facilitating the exchange of subunit NR2B by NR2A of
NMDA receptor [46]. Therefore, Reelin modulates synaptic plasticity events involved in
learning and memory processes in adults. Consistently with a role for Reelin in the control
of neurotransmission, reeler mice show diminished expression of presynaptic (SNARE,
SNAP-25) [44] and postsynaptic (PSD-95, PTEN) markers [43]. These defects cause failures
in the release of neurotransmitters, impairing synaptic transmission.
4. Animals models for neuropsychiatric diseases
Owing to the importance that Reelin have in the correct structuration and lamination of the
brain during development and in neuronal connectivity and synaptogenesis in the adult
brain, its dysfunction has been directly related to the generation or susceptibility to acquire
neuropsychiatric conditions such as depression and schizophrenia, or neurodegenerative
diseases such as Alzheimer’s disease (AD) [45].
The most tangible evidence supporting these putative relationships was obtained through
studies of human brains derived from neuropsychiatric and neurodegenerative conditions.
Decreased levels of Reelin are shown in postmortem samples from prefrontal cortex of pa‐
tients with schizophrenia and bipolar disorders [47]. This decrease may be explained in
schizophrenic patients by an abnormal hypermethylation of the reelin promoter, an epige‐
netic modification involved in gene silencing [48]. Furthermore, immunohistochemistry ex‐
periments in depressive and schizophrenic patients show decreased Reelin expression at the
hippocampus [49]. On the other hand, diminished Reelin levels in the hippocampus of pa‐
tients with AD had been reported, suggesting a direct correlation between the severity of the
disease and the extent of decreased Reelin expression [50]. All of these antecedents provide
evidence enough to feature a molecular link between decreased Reelin levels and neurode‐
generative/psychiatric diseases.
In order to understand the etiology of neurodegenerative/psychiatric diseases, different ani‐
mal models had been developed. A widely paradigm is the "two hit" model, which suggests
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that genetic and environmental factors may affect the development of central nervous sys‐
tem, acting as “the first hit”. These early disorders are linked to long-term vulnerability,
which after a “second hit” could cause the symptoms for a disease [51-52]. For diseases such
as depression, autism and schizophrenia, the heterozygous reeler mice had been used as the
genetic “first hit”, while stress events after the birth or in adulthood are used as the environ‐
mental “second hit”. The results indicate that heterozygous reeler mice, after a stressful
event, such as maternal deprivation or corticosterone injection, exhibit significantly in‐
creased depressive or schizophrenic behaviors as compared with wild type littermates
[53-54]. Indeed, reeler heterozygous animals in the absence of a stressful event, display a
phenotype indistinguishable from control animals [55].
The "two hit" model has also been used to study the molecular mechanisms leading to the
AD [56]. It is proposed that both oxidative stress and failures in mitotic signaling can inde‐
pendently triggers the onset of the disease; however both are necessary for their progression
[57]. In addition, a correspondence had been established between the Reelin expression in
the entorhinal cortex of aged rats with their cognitive abilities. A study revealed that aged
“cognitively disabled” rats show a significant decreased of Reelin in neurons on layer II of
the entorhinal cortex. Such a reduction in Reelin expression was not observed in juvenile or
elderly "cognitively able" rats [58].
Since Reelin is expressed from development to adult stages, is conceivable that alterations in
Reelin expression, induced by genetic or environmental factors generate a vulnerable stage,
and a secondary factor, present in normal aging, may trigger the onset and progression of a
pathological condition.
The Reelin-activated signaling pathways, which may be involved in the generation and de‐
velopment of AD are still unclear and will be discussed in next sections. In the last part of
this section, we present some of the evidences that correlate altered levels of Reelin and AD.
Pyramidal neurons placed in layer II of the entorhinal cortex and the hippocampus derived
from AD patients brains exhibit decreased Reelin expression [50]. On the other hand, an in‐
crease in the full length and 180 kD proteolytic fragment of Reelin had been observed in the
frontal cortex of AD derived samples [59]. The increase of this proteolytic fragment is attrib‐
uted to problems with the proteolysis of Reelin, associated with decreased Rab11-endocyto‐
sis of full length Reelin [60]. In the other hand, an increase of Reelin is also observed in the
frontal cortex of AD patients, which may involve a compensatory mechanism in response to
the lower expression in disease-related most vulnerable areas like the entorhinal cortex and
hippocampus [50].
The CR neurons participation in AD is a controversial issue. While electronic microscopy
analysis suggested that CR neurons of the temporal cortex were dramatically reduced in AD
patients [61], another study showed no difference between AD patients and normal, healthy
subjects [62]. On the other hand, there are some polymorphisms in the Reelin gene which
had been associated with AD. Seripa and colleagues reported significant differences in two
analyzed polymorphisms in the Reelin gene, in a group of 223 Caucasians AD patients.
These differences were exacerbated in female patients [63].
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Finally, Reelin had been associated with the pathological hallmarks for AD, the senile pla‐
ques and the neurofibrillary tangles (NFT). Reelin can modulate tau phosphorylation, the
core protein of NFT [38]. It is also associated with senile plaques, large extracellular aggre‐
gates mainly formed for β-amyloid peptide (Aβ). Immunohistochemical studies revealed
that Reelin colocalizes with the amyloid precursor protein (APP) in the neuritic component
of typical AD plaques, at the hippocampus and cortex of mice expressing a mutant version
of APP [64]. Additionally, a reduction of Reelin-producing cells had been observed in older
mice and primates. This reduction is accompanied by the presence of Reelin aggregates and
memory deficits. Mice harboring APP with AD-associated mutations also showed Reelin ag‐
gregates, which co-localized with non-fibrillar amyloid plaques [65]. In addition, Reelin
forms oligomeric or protofibrillary deposits during aging, potentially creating a precursor
condition for Aβ plaque formation [66].
A  direct  relationship  between  decreased  Reelin  expression  and  increased  levels  of  Aβ
peptide and plaque accumulation was provided by studies using transgenic mice carry‐
ing the APP Swedish and reeler mutation. The absence of Reelin expression resulted in an
age-dependent exacerbation of plaque pathology and increased NFTs in double mutants
as compared with the single APPsw mutant [67].  Finally,  recent studies demonstrated a
feedforward  mechanism  by  which  Reelin  would  favor  the  formation  of  senile  plaques;
and the subsequent Aβ peptide production would increase the Reelin levels by altering its
proteolytic processing in the cortex of mice and humans with AD [68].
5. Cytoskeletal abnormalities in Alzheimer´s disease
5.1. Tau protein and neurofibrillary tangles
Neurofibrillary tangles are amongst the standard characteristics of AD brains. These struc‐
tures  were firstly  described by Alois  Alzheimer more than a  century ago and are  com‐
posed  of  a  densely  packed  array  of  fibers  of  20  nm  in  diameter,  called  paired  helical
filaments  (PHF),  which  at  the  core  are  mainly  composed by  the  microtubule-associated
protein, tau [69-70]. Tau protein stabilizes and enhances microtubule polymerization. It is
a heterogeneous protein giving rise to 6 isoforms derived from alternative splicing [71]. It
contains 3 or 4 imperfect repeats of 31 or 32 amino acids each in tandem which confers
the  microtubule-binding  properties  of  the  protein.  These  repeats  are  enriched  in  basic
aminoacids  that  interact  electrostatically  with  the  mostly  acidic  C-terminal  of  β-tubulin
subunit [72]. Tau protein is highly phosphorylated in fetal brain [73], but minimally phos‐
phorylated in normal adult brain [74]. The abnormal phosphorylation state of several res‐
idues in tau protein plays an important role modulating the affinity to microtubules and
promoting its  aggregation [75]  forming the  core  of  PHFs [69,76-77].  Tau protein  can be
phosphorylated  by  many protein  kinases  such  as  calcium-calmodulin  dependent  kinase
[78];  PKA [79-81] and PKC [82-83].  Interestingly, many of these residues are hyperphos‐
phorylated in AD brains mainly due to an imbalance in the activity of kinases belongs to
the family of proline-directed Ser/Thr protein kinases (PDPKs), such as mitogen-activated
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protein kinases (MAPK) [84],  the glycogen synthase kinase (GSK)-3β [85],  JNK [84],  p38
[86] and Cyclin-dependent kinase (Cdk)-5 [87]. The abnormal phosphorylation state of tau
protein is not only contributed by protein kinases, but also by deregulated protein phos‐
phatases functions [88]. (Figure 1B)
5.2. Cofilin and actin-rods
NFTs are not the only intraneuronal cytoskeletal protein aggregates found in the brains of
patients  affected  by  AD.  Hirano´s  bodies  and  actin-rods  are  two  closely  related  aggre‐
gates primarily composed of actin and the actin binding protein, cofilin. Cofilin concerted‐
ly with the actin depolymerizing factor (ADF) constitutes the major modulators of actin
dynamic assembly.
Hirano’s bodies were originally described in 1965 and are defined as paracrystalline struc‐
tures, eosinophilic intracellular arrangements resembling rod-shaped filaments of 7 nm. The
actin-rods differ from Hirano´s bodies by it smaller size, so it is hypothesized that these
structures could be precursors of Hirano’s bodies.
The formation of actin-rods in neurons seems to be the result of several neurodegenerative
insults, such as ATP depletion, excitotoxic levels of glutamate, oxidative stress [89], and
Aβ1-42 oligomers [90]. A common event to all these stimuli triggers the formation of rods is
the dephosphorylation (activation) of cofilin [89]. Cofilin/ADF is inactivated by phosphory‐
lation of a highly conserved serine (Ser3), which precludes its binding to actin filaments and,
therefore, its role as promoters of filament severing and actin subunits turnover at the minus
end of filaments.
The Ser3 of ADF/cofilin is the only known substrate for the two isoforms of LIM domain
kinases  (LIM,  an  acronym for  three  Caenorhabditis  elegans  genes,  lin-11,  isl-1  and mec-3).
LIMKs is  activated by phosphorylation at  the Thr508,  mediated by PAK or ROCK, two
kinases that act as effectors for small GTPases Rac1 and RhoA respectively [91]. The regu‐
lation of signaling cascades, which target the functions of small GTPases, connect the dy‐
namic  control  of  the  actin  cytoskeleton  with  extracellular  signals.  In  AD,  different
components of  the signaling cascade involved in cofilin phosphorylation are altered,  in‐
cluding decreased phosphorylation of  PAK at  Ser141,  which is  necessary for  activation.
Although a decrease in phosphorylation and activity of PAK is observed in large areas of
cortex and hippocampus of AD brains,  neurons located near to amyloid plaques exhibit
strong staining for pSer141 PAK, suggesting that while the dephosphorylation is predom‐
inant in the brain of patients with AD, the amyloid fibrils present in amyloid plaques in‐
creases the activity of PAK [92].
Consistently, hippocampal neurons treated with fibrillar Aβ1-42 show increased activity of
PAK and its downstream substrate LIMK1 [93-94], most likely through a Rac1 and Cdc42
dependent mechanism [95]. Moreover, the treatment with oligomers of Aβ1-40 has the oppo‐
site effect, decreasing the phosphorylation of PAK, indicating that oligomeric forms may be
responsible for the overall reduction in PAK phosphorylation [92].
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Similarly, cofilin dephosphorylation and the subsequent formation of actin-rods seem to be
also a spatial-restricted phenomenon. In example, actin-rods occur in a subpopulation of
neurons in organotypic slices treated with Aβ [96]. (Figure 1B)
The mechanisms involved in the Aβ-mediated cofilin dephosphorylation are dependent on
changes in the activity of its upstream kinase, LIMK [90], and the activity of two known cofi‐
lin phosphatases, chronophin [97] and slingshot [94].
Interestingly, ATP depletion induces chronophin activation in a mechanism involving the
dissociation of chronophin-HSP90 complex. This mechanism would be responsible for the
formation of actin-rods under energy deprivation conditions [97].
6. Is the AD-associated Reelin reduction a major factor involved in the
neuronal cytoskeleton pathology?
6.1. Reelin reduction in AD brains
There is an increasing body of evidence indicating that a deficiency in Reelin signaling may
play a major role in the progression of AD. First, decreased Reelin expression is early ob‐
served in brains of AD transgenic mice model, even before Aβ deposition. Accordingly,
Reelin expression is also decreased in brains of patients at the presymptomatic stages of AD.
The progression of the disease causes in both cases, potentiate the Reelin deficiency from the
hippocampus to the entorhinal cortex in mice and from the frontal cortex to the hippocam‐
pus and entorhinal cortex in humans [50,98]. The decrease in Reelin expression is linked to a
reduction in CR cells at the cortical layer I in AD brains [61].
Reelin itself  can form amyloid deposits  in advanced stages of  AD, which can or cannot
be associated with Aβ senile plaques [64-66]. However, Aβ pathology seems to be a pre‐
requisite for the formation of Reelin aggregates, as these only occur after formation of se‐
nile plaques [98].
On  the  other  hand,  the  proteolytic  fragments  of  Reelin  showing  aberrant  glycosylation
pattern  are  increased  in  the  cerebrospinal  fluid  of  patients  with  AD [59,99].  Altogether
these  antecedents  support  the  hypothesis  that  the  Reelin  intracellular  signaling  is  im‐
paired at early stages of AD.
6.2. Cytoskeletal pathologies and Reelin signaling
Reelin signaling is triggered by the binding of Reelin to two members of the lipoprotein re‐
ceptor family, the very low density lipoprotein receptor (VLDLR) and the ApoE receptor 2
(ApoER2)[100]. The signal is then transduced by a cytoplasmic adapter protein, the mamma‐
lian homologue for the Drosophila protein disabled (mDab)-1, which interacts with the NPXY
motifs of the intracellular domain of several members of the LDL receptor family, including
VLDLR and ApoER2.
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As VLDLR/ApoER2 or mDab1 deficient mice exhibit a phenotype indistinguishable from re‐
eler mice, it is suggested that both receptors and the adapter protein can be linearly placed
on the same signal transduction pathway [37,101].
The binding of Reelin to its  receptors induces mDab1 tyrosine phosphorylation,  mediat‐
ed by non-receptor tyrosine kinases from the Src family [102]. The mutation of these ty‐
rosines  residues  by  phenylalanines  in  a  knockin  mouse  recapitulates  several  features  of
the  reeler  mouse,  supporting  that  these  phosphorylation  events  are  required  for  proper
Reelin signaling [103].
Several genetic models suggest that canonical Reelin signaling plays an essential role in con‐
trolling the phosphorylation state of tau and, therefore, modulating a critical event in the
progression of AD (Table 1).
Mice deficient in various components of the Reelin signaling pathway, including Reelin it‐
self, VLDLR, ApoER2 and Dab1 show increased tau phosphorylation in several AD-associ‐
ated epitopes, such as those recognized by the antibodies AT8 (pSer202/205) and PHF1
(pSer396/404) [38,104-106].
The increase in tau phosphorylation is caused by increased activity of two main kinases,
Cdk5 and GSK-3β [105], suggesting that Reelin is playing a negative control over the activi‐
ties of these kinases.
GSK-3β is normally inhibited by phosphorylation at its N-terminal region by the protein
kinase Akt, mainly at the Ser9. Reelin signaling in turn, activates Akt through its recruit‐
ment to membrane domains rich in phosphatidylinositol 3-phosphate (PIP3), whose forma‐
tion is involved the activity of the phosphatidilinositol 3-kinase (PI3K). Reelin activates PI3K
by potentiating the interaction between tyrosine phosphorylated-mDab1 and the p85α subu‐
nit of PI3K [107-108].
Moreover, it has been proposed that the increased activity of Cdk5 in Dab1 or Reelin defi‐
cient mice may be due to a remarkable increase of the proteolyzed form of a Cdk5 activa‐
tor, called p25 [105]. This fragment induces a non-physiological activation of Cdk5, which
is present mainly in pathological conditions, including brains of patients with AD [109].
Since the proteolysis of the Cdk5 activator is due to the activity of calpain, it may be hy‐
pothesized that the Reelin signaling pathway could regulate calpain-dependent proteoly‐
sis of p35.
It has been proposed that Cdk5 could not be directly regulated by the Reelin signaling cas‐
cade, because cortical neurons treated with Reelin do not exhibit any significant change in
the Cdk5 activity [107] or a diminished phosphorylation state of Cdk5-dependent substrates
[110]. However, it may not be ruled out that a subset of substrates still not analyzed can be
phosphorylated by Cdk5 due to impairment in Reelin signaling.
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Protein Functions in Reelin signaling Association with Alzheimer´s
disease
References
Reelin Extracellular matrix glycoprotein Diminished levels in restricted areas
of AD brain. Reelin-deficient mice
show increased tau phosphorylation
[50, 98]
ApoER2 Reelin receptor VLDLR and ApoER2 dKO mice
present elevated levels of
phosphorylated tau
[38]
VLDLR Reelin receptor VLDLR and ApoER2 dKO mice
present elevated levels of
phosphorylated tau
[38]
mDab1 Intracellular adapter for Reelin receptors mDab1-deficient mice show
increased tau phosphorylation and
early death.
[106]
PI3K Lipid kinase essential for membrane
recruiting of Akt
Impairment in PI3K-Akt pathway was
observed in aged APP-PS1 transgenic
mice.
[112]
Akt Phosphorylates and inhibits GSK-3β Impairment in PI3K-Akt pathway was
observed in aged APP-PS1 transgenic
mice.
[112]
GSK-3β Major tau kinase Phosphorylates tau at AD-associated
epitopes
[85]
tau Microtubule-associated protein. Promotes
microtubule assembly and stabilization
Hyperphosphorylated tau constitutes
the core of NFTs
[77]
Cdc42 Small GTPase associated with actin
dynamics
A lesser Aβ-induced actin-rod
formation is observed in cdc42 null
neurons
[96]
LIMK1 Major effector of Rho-family GTPases.
Phosphorylates and inactivates cofilin
The expression of constitutively
active LIMK1 reduces Aβ-induced
actin-rods in hippocampal slices
[90]
Cofilin Actin binding protein with F-actin
depolymerizing activity
Ser3 dephosphorylation triggers its
aggregation into actin-rods
[89]
Table 1. Association of Reelin signaling pathway with Alzheimer´s disease
The Reelin signaling pathway can target not only microtubule cytoskeleton, but also the ac‐
tin microfilament formation. Acting through its canonical signaling pathway that involve re‐
ceptors VLDLR and ApoER2, the adapter protein Dab1 and activation of PI3K, Reelin is able
to activate the small GTPases Rac1 and Cdc42, increasing actin polymerization. These
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changes in small Rho GTPases are responsible of increased mobility of growth cones and
promote the appearance of filopodia in the axon of cortical neurons in culture [111]. The sta‐
bilization of actin filaments is mediated directly by an increase in activation of LIMK and
phosphorylation of cofilin Ser3 [33]. LIMK and cofilin phosphorylation are two key events
that regulate actin microfilament turnover in a Rac-dependent manner. Currently, there are
no studies showing a causal relationship between impaired Reelin signaling and molecular
changes affecting cofilin phosphorylation that could regulate the formation of actin-rods.
However, it is tempting to speculate that further studies may solve a linkage between the
decreased Reelin signaling observed in AD brains and abnormal actin dynamics.
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